Werewolf Therapeutics to Participate in a Fireside Chat at the Jefferies Global Healthcare ConferenceGlobeNewsWire • 06/06/22
Werewolf Therapeutics Reports First Quarter 2022 Financial Results and Provides Business HighlightsGlobeNewsWire • 05/10/22
Werewolf Therapeutics Presents Promising Preclinical Data on its Two Lead INDUKINE™ Molecules at AACR 2022 Annual MeetingGlobeNewsWire • 04/08/22
Jazz Pharmaceuticals and Werewolf Therapeutics Announce Exclusive Global License and Collaboration Agreement to Develop WTX-613, a Differentiated, Conditionally-Activated IFNα INDUKINE™ MoleculePRNewsWire • 04/07/22
Werewolf Therapeutics Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Business HighlightsGlobeNewsWire • 03/24/22
Werewolf Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy of WTX-124 in Delivering IL-2 Selectively to the Tumor MicroenvironmentGlobeNewsWire • 03/16/22
Werewolf Therapeutics Announces Upcoming Presentations at AACR 2022 Annual MeetingGlobeNewsWire • 03/15/22
Werewolf Therapeutics to Present at the SVB Leerink Global Healthcare ConferenceGlobeNewsWire • 02/08/22
Werewolf Therapeutics to Present at the H.C. Wainwright Bioconnect ConferenceGlobeNewsWire • 01/05/22
Werewolf Therapeutics to Present Preclinical Data on INDUKINE™ Molecules at the 63rd American Society of Hematology (ASH) Annual MeetingGlobeNewsWire • 12/01/21
Werewolf Therapeutics Reports Third Quarter 2021 Financial Results and Business UpdateGlobeNewsWire • 11/10/21
Werewolf Therapeutics Appoints Meeta Chatterjee, Ph.D., to its Board of DirectorsGlobeNewsWire • 10/28/21
Werewolf Therapeutics to Present Data on its INDUKINE™ Product Candidates at the Society for Immunotherapy of Cancer Annual MeetingGlobeNewsWire • 10/27/21
Werewolf Therapeutics to Present at H. C. Wainwright Global Investment ConferenceGlobeNewsWire • 09/08/21
Werewolf Therapeutics Announces Clinical Trial Collaboration with Merck on its WTX-124 INDUKINE™ ProgramGlobeNewsWire • 08/18/21
Werewolf Therapeutics Reports Second Quarter 2021 Financial Results and Business UpdateGlobeNewsWire • 08/12/21